Pedersen, N.C., Ho, E.W., Brown, M.L. & Yamamoto, J.K.
Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science
235, 790–793 (1987).
et al. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol.
71, 6407–6415 (1997).
de Parseval, A. & Elder, J.H.
Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor. J. Virol.
75, 4528–4539 (2001).
de Parseval, A., Su, S.V., Elder, J.H. & Lee, B.
Specific interaction of feline immunodeficiency virus surface glycoprotein with human DC-SIGN. J. Virol.
78, 2597–2600 (2004).
de Parseval, A., Ngo, S. & Elder, J.H.
Factors that increase effective concentration of CXCR4 dictate feline immunodeficiency virus tropism and kinetics of replication. J. Virol.
78, 9132–9143 (2004).
et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature
312, 763–767 (1984).
et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature
312, 767–768 (1984).
Saphire, A.C., Bobardt, M.D., Zhang, Z., David, G. & Gallay, P.A.
Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J. Virol.
75, 9187–9200 (2001).
et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell
100, 587–597 (2000).
et al. Feline CD4 molecules expressed on feline non-lymphoid cell lines are not enough for productive infection of highly lymphotropic feline immunodeficiency virus isolates. Arch. Virol.
130, 171–178 (1993).
de Parseval, A., Chatterji, U., Sun, P. & Elder, J.H.
Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. USA
101, 13044–13049 (2004).
et al. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science
303, 1192–1195 (2004).
Sattentau, Q.J. & Moore, J.P.
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med.
174, 407–415 (1991).
Sattentau, Q.J., Moore, J.P., Vignaux, F., Traincard, F. & Poignard, P.
Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol.
67, 7383–7393 (1993).
et al. Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells. J. Virol.
73, 5373–5380 (1999).
et al. CD4-induced conformational changes in the human immunodeficiency virus type 1 gp120 glycoprotein: consequences for virus entry and neutralization. J. Virol.
72, 4694–4703 (1998).
et al. The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur. J. Immunol.
24, 677–683 (1994).
Kwon, B.S. & Weissman, S.M.
cDNA sequences of two inducible T-cell genes. Proc. Natl. Acad. Sci. USA
86, 1963–1967 (1989).
et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell
66, 233–243 (1991).
et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell
61, 351–359 (1990).
et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell
68, 421–427 (1992).
Camerini, D., Walz, G., Loenen, W.A., Borst, J. & Seed, B.
The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family. J. Immunol.
147, 3165–3169 (1991).
et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell
61, 361–370 (1990).
et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science
248, 1019–1023 (1990).
Stamenkovic, I., Clark, E.A. & Seed, B.
A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J.
8, 1403–1410 (1989).
et al. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol.
73, 4991–5000 (1999).
et al. Crystal structure of the soluble human 55 kd TNF receptor-human TNF β complex: implications for TNF receptor activation. Cell
73, 431–445 (1993).
et al. Identification of the residues in human CD4 critical for the binding of HIV. Cell
57, 469–481 (1989).
Landau, N.R., Warton, M. & Littman, D.R.
The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature
334, 159–162 (1988).
et al. Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes. J. Exp. Med.
170, 1319–1334 (1989).
Peterson, A. & Seed, B.
Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4. Cell
54, 65–72 (1988).
et al. Substitution of murine for human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature
335, 363–366 (1988).
Mizukami, T., Fuerst, T.R., Berger, E.A. & Moss, B.
Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis. Proc. Natl. Acad. Sci. USA
85, 9273–9277 (1988).
Schockmel, G.A., Somoza, C., Davis, S.J., Williams, A.F. & Healey, D.
Construction of a binding site for human immunodeficiency virus type 1 gp120 in rat CD4. J. Exp. Med.
175, 301–304 (1992).
et al. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature
348, 411–418 (1990).
et al. Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature
348, 419–426 (1990).
Naismith, J.H., Devine, T.Q., Brandhuber, B.J. & Sprang, S.R.
Crystallographic evidence for dimerization of unliganded tumor necrosis factor receptor. J. Biol. Chem.
270, 13303–13307 (1995).
Naismith, J.H., Devine, T.Q., Kohno, T. & Sprang, S.R.
Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure
4, 1251–1262 (1996).
Al-Shamkhani, A., Mallett, S., Brown, M.H., James, W. & Barclay, A.N.
Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells. J. Biol. Chem.
272, 5275–5282 (1997).
Arch, R.H. & Thompson, C.B.
4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol. Cell. Biol.
18, 558–565 (1998).
Kawamata, S., Hori, T., Imura, A., Takaori-Kondo, A. & Uchiyama, T.
Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-κB activation. J. Biol. Chem.
273, 5808–5814 (1998).
et al. OX40-mediated memory T cell generation is TNF receptor-associated factor 2 dependent. J. Immunol.
171, 5997–6005 (2003).
Chan, D.C., Fass, D., Berger, J.M. & Kim, P.S.
Core structure of gp41 from the HIV envelope glycoprotein. Cell
89, 263–273 (1997).
Weissenhorn, W., Dessen, A., Harrison, S.C., Skehel, J.J. & Wiley, D.C.
Atomic structure of the ectodomain from HIV-1 gp41. Nature
387, 426–430 (1997).
et al. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature
384, 184–187 (1996).
et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature
384, 179–183 (1996).
Ali, S.A. & Steinkasserer, A.
PCR-ligation-PCR mutagenesis: a protocol for creating gene fusions and mutations. Biotechniques
18, 746–750 (1995).
et al. Comparison of two host cell range variants of feline immunodeficiency virus. J. Virol.
64, 4605–4613 (1990).
De Clercq, E.
et al. Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob. Agents Chemother.
38, 668–674 (1994).
Engelman, D.M., Steitz, T.A. & Goldman, A.
Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu. Rev. Biophys. Chem.
15, 321–353 (1986).